Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Eli Lilly struck a deal Tuesday to develop ...

April 28 (Reuters) - AI firm Profluent said on Tuesday it has struck a multi-program research collaboration with U.S. drugmaker Eli Lilly (LLY.N), opens new tab worth up ‌to $2.25 billion to develop ...

The governor’s office has dismissed experts’ concerns that his criminal justice rollbacks could swell the prison population and plunge the state into financial disaster. We analyzed how his policies ...

California, US AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25 billion, that will focus on gene-editing therapies. Profluent has attracted attention ...

With over a decade of editorial experience, Rob Watts breaks down complex topics for small businesses that want to grow and succeed. His work has been featured in outlets such as Keypoint Intelligence ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal includes an upfront ...

Collaboration combines Profluent's frontier AI platform with Lilly's leading capabilities in genetic medicines AI-designed recombinases aim to unlock kilobase-scale DNA editing capabilities across ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the Big Pharma team up with Profluent to develop AI-designed recombinases to address diseases with severe unmet needs.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A quick look at the table above will show that these two phones are very similar. This isn’t surprising, as they are only a generation apart so upgrades tend to be incremental rather than ...

April 28 : AI firm Profluent said on Tuesday it has struck a multi-program research collaboration with U.S. drugmaker Eli Lilly worth up to $2.25 billion to develop AI-designed enzymes for genetic ...